Keyrus S.A. (LON:0NCF)
8.42
+0.16 (1.94%)
At close: Dec 17, 2025
Keyrus Revenue
Keyrus had revenue of 170.25M EUR in the half year ending June 30, 2025, a decrease of -8.84%. This brings the company's revenue in the last twelve months to 346.70M, down -4.15% year-over-year. In the year 2024, Keyrus had annual revenue of 354.59M, down -4.25%.
Revenue (ttm)
346.70M EUR
Revenue Growth
-4.15%
P/S Ratio
0.39
Revenue / Employee
117.60K EUR
Employees
2,948
Market Cap
116.46M GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 354.59M | -15.75M | -4.25% |
| Dec 31, 2023 | 370.34M | 18.45M | 5.24% |
| Dec 31, 2022 | 351.89M | 62.70M | 21.68% |
| Dec 31, 2021 | 289.19M | 28.26M | 10.83% |
| Dec 31, 2020 | 260.93M | -25.78M | -8.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |